Edwards Lifesciences Corp

+0.58 (+0.52%)
4:00:00 PM EDT: $112.22 +0.07 (+0.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)70.28B
Current PE48.06
Forward PE 49.41
2yr Forward PE 43.47
See more stats
Estimates Current Quarter
Revenue$1.33 Billion
Adjusted EPS$0.54
See more estimates
10-Day MA$110.86
50-Day MA$115.90
200-Day MA$98.49
See more pivots

Edwards Lifesciences Corp Stock, NYSE:EW

One Edwards Way, Irvine, California 92614
United States of America
Phone: +1.949.250.2500
Number of Employees: 14900


Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.